A 3rd/4th Line Placebo-Controlled Trial of Sorafenib in Patients With Predominantly Non Squamous Non-Small Cell Lung Cancer NSCLC.

Authors
Category Primary study
Registry of TrialsClinical Trials Registry - India
Year 2009
This article has no abstract
Epistemonikos ID: 7bb63e085d7c788d5a0a9c05326412bc35806663
First added on: Apr 16, 2025